For over a decade, the Solitaire™ Revascularization Device has supported you in helping patients with a better chance of recovery. The Solitaire X offers optimized delivery and ease of use1,3 while retaining the clinically proven13 features of Solitaire you’ve come to depend on.
The optimized delivery system produces lower delivery force3 for improved procedural efficiency and smooth navigation through even the most complicated anatomy.LEARN MORE ABOUT SOLITAIRE
When combined with a 0.021” microcatheter, Solitaire X provides smooth and adaptable deliverability with a lower clot crossing profile.3
The Phenom™ 21 Catheter is our longest 0.021” microcatheter.
The 160cm microcatheter allows increased access for:
The Solitaire X revascularization device enables reliable and effective use in vessels as small as 2.0mm, so you can confidently treat distal occlusions out to M2.
Solitaire X is indicated to treat large vessel occlusions (LVO) from ICA to M1 within 6-16 hours after symptom onset.4
TR-NV16168 Rev A
TR-NV12692 Rev A
Compared to Solitaire™ Platinum
71042-001 Rev B
Umansky, F. et al. Microsurgical anatomy of the proximal segments of the middle cerebral artery
TR-NV13807 Rev A
TR-NV12180 Rev A
DWGSFG13XXX-YYyy-Zz Rev B
DWGSFG15XXX-YYyy-Zz Rev B
Solitaire™ FR Received CE Marking 2009
TR-NV15666A Rev A
Phenom 21 Catheter
STRATIS, SWIFT PRIME, ESCAPE, Nasa Registry, THRACE, MR CLEAN, STAR, EXTEND IA, HERMES, SEER, REVASCAT, DEFUSE 3, Note: The Solitaire™ X Revascularization Device was not evaluated in these studies.